Roche Holding AG Logo

Roche Holding AG

Global healthcare company focused on pharmaceuticals and diagnostics.

RO | SW

Overview

Corporate Details

ISIN(s):
CH0012032048 (+1 more)
LEI:
549300U41AUUVOAAOB37
Country:
Switzerland
Address:
Grenzacherstr. 124, 4058 Basel

Description

Roche Holding AG is a global healthcare company focused on advancing science to improve health outcomes. The company operates through two primary divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals division discovers, develops, and manufactures innovative medicines across major therapeutic areas, including oncology, immunology, infectious diseases, ophthalmology, and neuroscience. The Diagnostics division provides a comprehensive portfolio of in-vitro diagnostic tests, instruments, and digital solutions that aid in the prevention, diagnosis, and monitoring of diseases. By combining its strengths in both pharmaceuticals and diagnostics, Roche aims to deliver personalized healthcare solutions that address unmet medical needs for patients worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2004-12-31 00:00
Annual Report 2004
English 8.5 MB
2004-12-31 00:00
Jahresbericht 2004
German 8.8 MB
2004-04-22 00:00
Presentation to analysts First Quarter 2004 Basle, April 21, 2004
English 1.2 MB
2003-12-31 00:00
Annual Report 2003
English 8.4 MB
2003-12-31 00:00
Jahresbericht 2003
German 8.5 MB
2003-07-25 00:00
First Half 2003 Presentation to analysts
English 1.1 MB
2003-04-11 00:00
26 March 2003Roadshow USANew York
English 175.9 KB
2003-04-10 00:00
Company Presentation 2003
English 250.3 KB
2003-02-12 00:00
16 January 2003 Roadshow Germany
English 323.7 KB
2002-12-31 00:00
Annual Report 2002
English 9.3 MB
2002-12-31 00:00
Jahresbericht 2002
German 9.7 MB

Automate Your Workflow. Get a real-time feed of all Roche Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Roche Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Roche Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-16 N/A Executive member Sell None 1,494,248.20 CHF
2025-02-07 N/A Non-Executive member Buy None 613,652.00 CHF
2024-07-26 N/A Non-Executive member Sell None 1,743,760.00 CHF
2024-07-25 N/A Non-Executive member Sell None 723,460.00 CHF
2024-06-21 N/A Executive member Sell None 2,220,432.00 CHF
2024-06-10 N/A Executive member Sell None 1,260,138.00 CHF
2024-05-29 N/A Non-Executive member Buy None 504,400.00 CHF

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.